文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

帕金森病中的免疫系统:目前我们所知的。

The immune system in Parkinson's disease: what we know so far.

机构信息

Centre for Molecular Biology and Regenerative Medicine-CABIMER, University of Seville-CSIC, Seville 41092, Spain.

Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville, Seville 41009, Spain.

出版信息

Brain. 2024 Oct 3;147(10):3306-3324. doi: 10.1093/brain/awae177.


DOI:10.1093/brain/awae177
PMID:38833182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11449148/
Abstract

Parkinson's disease is characterized neuropathologically by the degeneration of dopaminergic neurons in the ventral midbrain, the accumulation of α-synuclein (α-syn) aggregates in neurons and chronic neuroinflammation. In the past two decades, in vitro, ex vivo and in vivo studies have consistently shown the involvement of inflammatory responses mediated by microglia and astrocytes, which may be elicited by pathological α-syn or signals from affected neurons and other cell types, and are directly linked to neurodegeneration and disease development. Apart from the prominent immune alterations seen in the CNS, including the infiltration of T cells into the brain, more recent studies have demonstrated important changes in the peripheral immune profile within both the innate and adaptive compartments, particularly involving monocytes, CD4+ and CD8+ T cells. This review aims to integrate the consolidated understanding of immune-related processes underlying the pathogenesis of Parkinson's disease, focusing on both central and peripheral immune cells, neuron-glia crosstalk as well as the central-peripheral immune interaction during the development of Parkinson's disease. Our analysis seeks to provide a comprehensive view of the emerging knowledge of the mechanisms of immunity in Parkinson's disease and the implications of this for better understanding the overall pathogenesis of this disease.

摘要

帕金森病的神经病理学特征是腹侧中脑中多巴胺能神经元的退化、神经元中α-突触核蛋白(α-syn)聚集物的积累和慢性神经炎症。在过去的二十年中,体外、离体和体内研究一致表明,小胶质细胞和星形胶质细胞介导的炎症反应的参与,这可能是由病理性α-syn 或受影响神经元和其他细胞类型的信号引发的,并且与神经退行性变和疾病发展直接相关。除了中枢神经系统中明显的免疫改变,包括 T 细胞浸润大脑,最近的研究还表明,固有和适应性免疫成分中,外周免疫特征发生了重要变化,特别是涉及单核细胞、CD4+和 CD8+T 细胞。本综述旨在整合对帕金森病发病机制中与免疫相关的过程的综合认识,重点关注中枢和外周免疫细胞、神经元-胶质细胞相互作用以及帕金森病发展过程中的中枢-外周免疫相互作用。我们的分析旨在提供对帕金森病免疫机制的新兴知识的全面了解,以及这对更好地理解这种疾病的整体发病机制的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/11449148/cba55b861728/awae177f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/11449148/d3306c5ebffd/awae177f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/11449148/cba55b861728/awae177f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/11449148/d3306c5ebffd/awae177f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/11449148/cba55b861728/awae177f2.jpg

相似文献

[1]
The immune system in Parkinson's disease: what we know so far.

Brain. 2024-10-3

[2]
Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.

J Parkinsons Dis. 2024

[3]
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.

Brain. 2021-8-17

[4]
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.

J Neuroinflammation. 2020-8-15

[5]
Immune system responses in Parkinson's disease: Early and dynamic.

Eur J Neurosci. 2018-12-10

[6]
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

J Neurosci. 2016-5-4

[7]
The major histocompatibility complex participates in Parkinson's disease.

Pharmacol Res. 2024-5

[8]
Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.

PLoS One. 2013-8-23

[9]
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.

J Neuroinflammation. 2018-8-30

[10]
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.

Int J Mol Sci. 2021-6-17

引用本文的文献

[1]
The Mediation of Circulating Inflammatory Proteins in the Causal Pathway From Immune Cells to Delirium.

Brain Behav. 2025-9

[2]
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's disease.

Front Immunol. 2025-7-23

[3]
Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson's disease.

Front Cell Neurosci. 2025-7-18

[4]
Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.

NeuroImmune Pharm Ther. 2025-6-20

[5]
Integrated Single-Cell and Spatial Transcriptomic Analysis Identifies ISR-Related Genes Driving Immune Regulation in Parkinson's Disease.

J Inflamm Res. 2025-7-15

[6]
Bridging the Gap: The Neuro-immune Axis as a Key Player in Neurodegenerative Disorders.

Neurosci Bull. 2025-6-25

[7]
Peripheral inflammation's variable impact on cognitive and symptomatic outcomes in Parkinson's disease: a longitudinal and cross-sectional analysis.

NPJ Parkinsons Dis. 2025-6-7

[8]
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.

Behav Brain Funct. 2025-5-31

[9]
Synapse vulnerability and resilience across the clinical spectrum of dementias.

Nat Rev Neurol. 2025-5-22

[10]
Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update.

Acta Pharmacol Sin. 2025-5-19

本文引用的文献

[1]
Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study.

Exp Neurol. 2024-2

[2]
Regulation of Pain Perception by Microbiota in Parkinson Disease.

Pharmacol Rev. 2023-12-15

[3]
Neuroinflammation is linked to dementia risk in Parkinson's disease.

Brain. 2024-3-1

[4]
Toll-like Receptor 4 Is Upregulated in Parkinson's Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology.

Cells. 2023-5-11

[5]
Differential intracellular trafficking of extracellular vesicles in microglia and astrocytes.

Cell Mol Life Sci. 2023-6-30

[6]
Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease.

Nat Commun. 2023-6-26

[7]
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.

Nat Commun. 2023-6-20

[8]
Intermittent Theta Burst Stimulation Improves Motor and Behavioral Dysfunction through Modulation of NMDA Receptor Subunit Composition in Experimental Model of Parkinson's Disease.

Cells. 2023-6-1

[9]
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients.

Parkinsonism Relat Disord. 2023-7

[10]
Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis.

Acta Neuropathol. 2023-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索